Skip to main content

Advertisement

Table 4 An empirical approach to cholesterol-lowering therapies in patients with diabetes.

From: Designing theoretically-informed implementation interventions

There is a concern that primary care physicians are under-prescribing cholesterol-lowering therapy to patients with diabetes.
Physicians are interviewed leading to the identification of specific barriers to this behaviour: a lack of knowledge of recent research evidence about cholesterol-lowering therapy and concerns about serious drug side-effects.
This leads to an intervention that has two components: an educational component summarising recent relevant research evidence about cholesterol-lowering therapy and the presentation of prevalence data of the drug side-effects and their consequences.